SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-21-063655
Filing Date
2021-12-06
Accepted
2021-12-06 16:39:12
Documents
5

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea151632-s3_adialpharm.htm S-3 309973
2 OPINION OF GRACIN & MARLOW, LLP ea151632ex5-1_adialpharm.htm EX-5.1 7660
3 CONSENT OF FRIEDMAN LLP ea151632ex23-1_adialpharm.htm EX-23.1 3219
4 GRAPHIC ex5-1_001.jpg GRAPHIC 4054
5 GRAPHIC image_001.jpg GRAPHIC 6020
  Complete submission text file 0001213900-21-063655.txt   336218
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-261509 | Film No.: 211473578
SIC: 2834 Pharmaceutical Preparations